Systemic Embolism

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination [NA]

  A pivotal IDE study on laminar left atrial appendage elimination for non-valvular atrial fibrillation is currently suspended.

• CLINICAL_TRIALS trial_result · 2026-03-24
  Clinical Trial Update: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial [NA]

  AtriCure's Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction trial is listed as ACTIVE_NOT_RECRUITING, indicating the study …

• CLINICAL_TRIALS trial_result · 2026-03-12
  Clinical Trial Update: The Fourth Left Atrial Appendage Occlusion Study [NA]

  This clinical-trial update covers the Fourth Left Atrial Appendage Occlusion Study, a trial evaluating left atrial appendage occlusion in pa…

• CLINICAL_TRIALS trial_result · 2021-01-22
  Clinical Trial Update: Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation [Phase 2, Phase 3]

  Clinical trial update comparing apixaban to warfarin for managing postoperative atrial fibrillation after coronary artery bypass grafting; c…

• CLINICAL_TRIALS trial_result · 2014-06-23
  Clinical Trial Update: Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk [Phase 4]

  A Phase 4 study from Biotronik evaluated combining their home monitoring system with predefined anticoagulation to reduce stroke risk in pat…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-07-17
  Clinical Trial Update: An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation [Phase 3]

  Phase 3 clinical trial update evaluating rivaroxaban with warfarin for prevention of stroke and non-CNS systemic embolism in patients with n…